During the 2018 Miami Breast Cancer Conference, Dr. Elizabeth A. Mittendorf discussed immunotherapy concepts and strategies related to breast cancer.
Lisinopril and carvedilol reduced cardiotoxicity in patients with HER2-positive breast cancer treated with trastuzumab and anthracyclines.
STING (stimulator of interferon genes) inhibitors have been shown to help T cells thrive and work synergistically with other cancer therapies, so new trials are underway to test whether they can be used to improve response in certain patients.
Substantial variation in treatment patterns can explain geographic differences in survival outcomes in patients with lung cancer, according to a UK study.
How much do you understand about evaluating prognosis and choosing treatment for patients with myeloma? Take our latest quiz to find out.
The FDA has granted Breakthrough Therapy and Fast Track designation to GC4419, for reduction of severe oral mucositis caused by radiation therapy.
A 34-year-old man presents with axillary lymphadenopathy, and a biopsy is obtained. What is your diagnosis?
A breast nodule is found in a 42-year-old woman, and a biopsy is performed. What is your diagnosis?
A 58-year-old man presents with a mass in his larynx, and a biopsy is obtained. What is your diagnosis?
Some patients with HER2-positive breast cancer may develop an immunosuppressive phenotype based on an increase in regulatory T cells following treatment.
The oral therapy combination of ixazomib, pomalidomide, and dexamethasone was effective and well-tolerated in patients with myeloma that had relapsed or was refractory to lenalidomide.
In this UK observational study, being obese was linked with an increased risk for colorectal cancer but undergoing prior obesity surgery was not.
Late last year, ONCOLOGY hosted a writing contest on Cancer Network, in which we asked our readers to share their personal experiences with delivering bad news. Dr. Trevor Bayliss submitted a piece about his experience as a young patient, and how that influenced his decision to become an oncologist.
A 60-year-old man presents with a lesion in the submandibular area, and a biopsy is obtained. What is your diagnosis?
Umbralisib, a dual inhibitor of PI3Kδ and casein kinase-1Ɛ, was well tolerated and showed early signs of clinical activity in a phase I lymphoma study.